Therapeutic effect dependent on timing of combination treatment with chemotherapy and allogeneic lymphoid cell transfer in rats.
D000818:Animals; D002471:Cell Transformation, Neoplastic; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005354:Fibrosarcoma / Q000401:mortality / Q000628:therapy*; D005472:Fluorouracil / Q000031:analogs & derivatives*; D007116:Immunization, Passive; D017710:Lymphocyte Transfusion; D051381:Rats; D011919:Rats, Inbred Strains; D005641:Tegafur / Q000627:therapeutic use*; D013997:Time Factors; D014184:Transplantation, Homologous
D005641:Tegafur; D003520:Cyclophosphamide; D005472:Fluorouracil